The biological activities that are driven by the HGF-MET pathway all play a role in the acquisition of malignant characteristics by tumor cells, namely, invasion, metastasis, and drug resistance in the tumor microenvironment (Figure 1) [1,2,3]. This evidence concerns the gene MET and neoplasm.